-

Shareholder Alert: Robbins LLP is Investigating the Officers and Directors of Fifth Third Bancorp (FITB) on Behalf of Shareholders

SAN DIEGO & CINCINNATI--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Fifth Third Bancorp (NASDAQ: FITB) for potential material misstatements and violations of federal securities laws pursuant to its March 2019 acquisition of MB Financial, Inc. On March 21, 2018, Fifth Third Bancorp and MB Financial announced the signing of a merger agreement in which MB Financial would merge with Fifth Third in a transaction valued at approximately $4.7 billion. Shareholders of MB Financial received 1.45 shares of Fifth Third common stock and $5.54 in cash for each share of MB Financial common stock they owned. The merger was completed on March 22, 2019. Since the merger, shares of Fifth Third have declined precipitously, and it currently trades at around $18 per share.

If you received shares of Fifth Third Bancorp stock in the March 2019 acquisition, click here.

Fifth Third Bancorp (FITB) Shareholders Have Legal Options

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Fifth Third settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
llevi@robbinsllp.com
(800) 350-3990 or (619) 525-3990
www.robbinsllp.com

More News From Robbins LLP

Investor Alert: Robbins LLP Informs Investors of the Corcept Therapeutics Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Corcept Therapeutics Incorporation (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025. Corcept is a pharmaceutical company focused on the development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. For more information, submi...

ARDT Class Action Reminder: Stockholders Who Lost Money Investing in Ardent Health, Inc. Should Contact Robbins LLP for Information About Recovering Their Losses

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2025 and November 12, 2025. Ardent Health and its affiliates operate acute care hospitals and other healthcare facilities. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the allegations? Robbins LLP is Investigating...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the NuScale Power Corporation Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired NuScale Power Corporation (NYSE: SMR) Class A shares between May 13, 2025 and November 6, 2025. NuScale is a nuclear technology company focused on scalable, modular reactors. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that...
Back to Newsroom